Pembrolizumab for previously treated, microsatellite instability–high/mismatch repair–deficient advanced colorectal cancer: final analysis of KEYNOTE-164

2023/06/01 by Dung T. Le, Luis A. Diaz, Tae Won Kim +17 · 1 citation

paper · doi:10.1016/j.ejca.2023.02.016

Cited by

• SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials